CMAB008

· Shanghai Biomabs Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CMAB008, covering 2020-03-18 to 2020-03-18. Get the full timeline:

Most recent: Clinical Trial Update: CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid Arthritis [Phase 3]